ResMed dominates healthcare devices with innovation, recurring revenues, and market leadership. See why we believe RMD stock ...

ResMed Inc (RMD) reports an 8% revenue increase and plans to boost share buybacks, while navigating global trade challenges ...

While US President Donald Trump's tariffs have sent global markets into a tailspin, medical technology companies are ...

Shares edge higher; gold stocks bounce back; Westpac tips 25bps May cut, fears tariff fallout; Resmed, Tesla rally; gold ...

Shares edge higher; Trump to reportedly wind down tariff rate on China; Tesla leaps 5pc; ResMed evades trade war blow; iron ...

Discover ResMed's Q3 2025 earnings highlights, including 8% revenue growth, margin expansion, new product launches, and strategic investments in ...

Resmed beat Wall Street estimates for third-quarter profit on Wednesday, driven by demand for its sleep apnea devices used to manage the common sleep disorder.

Resmed beat Wall Street estimates for third-quarter profit on Wednesday, driven by demand for its sleep apnea devices used to manage the common sleep disorder. The company manufactures continuous ...

Unveiled the findings of our fifth annual Global Sleep Survey. With insights from 30,026 respondents across 13 markets, the study underscored a widespread global sleep crisis, with people losing an ...

Medical device company ResMed (NYSE:RMD) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 7.9% year on year ...

Morgans senior healthcare analyst Scott Power says healthcare stocks have had a strong start to the latest reporting season.

ResMed Inc. (ASX: RMD) shares are having a strong finish to the week. Here's why investors are buying this blue chip ...